Further studies should examine the expressions of CD47 and CD24 at the transcriptional levels to further understand the mechanism of CD47/SIRPα and CD24/Siglec‐1 pathways in the anti‐tumor immune response. This evidence concerns the gene CD24 and neoplasm.